A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups

Overview of attention for article published in Orphan Drugs: Research and Reviews, February 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 news stories from 1 outlets.

BioMarin Pharmaceutical (BMRN) made progress regarding its pipeline when it commenced dosing in a phase III study (:INSPIRE) on…

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today the formation of a…